Phase III, randomized, double-blind, placebo-controlled clinical study: a study on the safety and clinical efficacy of AZVUDINE in moderate COVID-19 patients
de Souza$n$ et al., Frontiers in Medicine, doi:10.3389/fmed.2023.1215916
https://c19early.org/desouza2.html